Phase 1-ready biotech developing oral small molecule therapies for immunologic diseases.
Industry: Health Care
Latest Trade: $47.55 0.00 (0.0%)
First Day Return: +117.0%
Return from IPO: +179.7%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 08/25/2021 |
Offer Price | $17.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 12.0 |
Deal Size ($mm) | $204 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 09/14/2021 |
Offer Price | $17.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 12.0 |
Deal Size ($mm) | $204 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
BofA Securities |
Leerink Partners |
more |
Company Data | |
---|---|
Headquarters | South San Francisco, CA, United States |
Founded | 2013 |
Employees at IPO | 32 |
Website www.dicemolecules.com |